US FDA final rule confirms IVD exception to informed consent requirements
This article was originally published in RAJ Devices
The US Food and Drug Administration has published a final rule that confirms a new exception concerning in vitro diagnostics to the general requirements on informed consent but includes a measure to protect against this exception being misused1,2
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.